By European cannabis researcher and thought-leader Kenzi Riboulet-Zemouli
THERE is much concern over the International Narcotics Control Board’s Cannabis Control Initiative, as reported by BusinessCann earlier...
THE newly launched Cannabis Industry Council has brought together disparate organisations, working groups and businesses with the aim of driving meaningful change within the...
By: Max Monahan-Ellison
AS hype and excitement builds around the potential for recreational cannabis legalization in some European countries, it’s an opportune time to share...
By Peter Reynolds, of CannaPro
THIS is the story of how brave British small-businesses created a £1.7bn market and now face destruction at the hands...
Dr Paul Duffy, Toxicology Associate, at the ACI, elaborates on its Novel Food applications and the significance of these development for the the CBD industry
THIS...
Prof Mike Barnes, one of the UK's leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced...
Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA.
UNDER a...
Leading cannabis Lawyer Robert Jappie of law firm Ince reflects on the shifting status of CBD in Europe
THE European Commission has paused consideration of...
Alex Fraser, Patient Access Lead with Grow Pharma, on the recently-launched 'Open Cannabis' campaign
THE truth is there are a huge number of patients...
AUSTRIAN seed-to-sale CBD firm MAGU says the future looks brighter under a new cannabis-friendly Government. Co-Founder Sofie Sagmeister elaborates.
“COVID-19 has hit us hard -...
BEFORE heading off to Greece to persuade its politicians to commit to the cannabis industry, former Canopy Growth Chief Executive Bruce Linton elaborated on...
MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...